Amy Guppy

693 total citations
10 papers, 298 citations indexed

About

Amy Guppy is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Amy Guppy has authored 10 papers receiving a total of 298 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 3 papers in Surgery and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Amy Guppy's work include Ovarian cancer diagnosis and treatment (3 papers), Cancer Treatment and Pharmacology (3 papers) and Advanced Breast Cancer Therapies (2 papers). Amy Guppy is often cited by papers focused on Ovarian cancer diagnosis and treatment (3 papers), Cancer Treatment and Pharmacology (3 papers) and Advanced Breast Cancer Therapies (2 papers). Amy Guppy collaborates with scholars based in United Kingdom, Australia and United States. Amy Guppy's co-authors include Gordon Rustin, Paul Nathan, Niall C. Tebbutt, A. Norman, David Cunningham, Lisa Pickering, Mariam Jamal‐Hanjani, P L Amlot, Ann E. Nelstrop and Roshan Agarwal and has published in prestigious journals such as British Journal of Cancer, Transplantation and The Oncologist.

In The Last Decade

Amy Guppy

9 papers receiving 290 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amy Guppy United Kingdom 6 112 105 80 67 63 10 298
Raj Nagarkar India 5 96 0.9× 101 1.0× 111 1.4× 26 0.4× 56 0.9× 33 257
Wolfram Jaeger Germany 10 115 1.0× 121 1.2× 91 1.1× 90 1.3× 53 0.8× 20 356
Jean Torrisi United States 7 51 0.5× 122 1.2× 72 0.9× 67 1.0× 25 0.4× 11 307
Seyran Yiğit Türkiye 14 95 0.8× 181 1.7× 76 0.9× 74 1.1× 66 1.0× 43 433
Alessia Romito Italy 11 209 1.9× 118 1.1× 98 1.2× 49 0.7× 30 0.5× 19 394
Alessandra Bologna Italy 12 188 1.7× 288 2.7× 118 1.5× 50 0.7× 31 0.5× 37 421
Alina Abramian Germany 11 63 0.6× 165 1.6× 78 1.0× 57 0.9× 29 0.5× 30 372
O. Nascimben Italy 11 63 0.6× 173 1.6× 118 1.5× 67 1.0× 36 0.6× 21 352
Carmelo Bengala Italy 9 46 0.4× 176 1.7× 55 0.7× 41 0.6× 24 0.4× 19 320
G. Rangoni Italy 10 143 1.3× 111 1.1× 45 0.6× 69 1.0× 20 0.3× 26 362

Countries citing papers authored by Amy Guppy

Since Specialization
Citations

This map shows the geographic impact of Amy Guppy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Guppy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Guppy more than expected).

Fields of papers citing papers by Amy Guppy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy Guppy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Guppy. The network helps show where Amy Guppy may publish in the future.

Co-authorship network of co-authors of Amy Guppy

This figure shows the co-authorship network connecting the top 25 collaborators of Amy Guppy. A scholar is included among the top collaborators of Amy Guppy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy Guppy. Amy Guppy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Ghose, Aniruddha, Dongyun Yang, Angela Swampillai, et al.. (2023). 232P Real-world study of sacituzumab govitecan in metastatic triple-negative breast cancer in the United Kingdom. ESMO Open. 8(1). 101420–101420. 3 indexed citations
2.
Okines, Alicia, Benjamin M. Sanderson, Ruth Board, et al.. (2022). A Multicentre Retrospective Study of Fulvestrant Use and Efficacy in Advanced/Metastatic Breast Cancer. Clinical Oncology. 34(4). 261–266. 4 indexed citations
3.
Miles, David, et al.. (2022). A service evaluation of joint working across sectors to promote self-administration of subcutaneous systemic anti-cancer therapy in breast cancer patients. International Journal of Pharmacy Practice. 30(Supplement_2). ii17–ii18.
4.
Henriksen, Peter, Peter Hall, Olga Oikonomidou, et al.. (2022). Rationale and Design of the Cardiac CARE Trial: A Randomized Trial of Troponin-Guided Neurohormonal Blockade for the Prevention of Anthracycline Cardiotoxicity. Circulation Heart Failure. 15(7). e009445–e009445. 4 indexed citations
5.
Guppy, Amy, Mariam Jamal‐Hanjani, & Lisa Pickering. (2011). Anticancer Effects of Metformin and Its Potential Use as a Therapeutic Agent for Breast Cancer. Future Oncology. 7(6). 727–736. 33 indexed citations
6.
Guppy, Amy, E Rawlings, J. Alejandro Madrigal, P L Amlot, & Linda D. Barber. (2007). A Quantitative Assay for Epstein-Barr Virus–Specific Immunity Shows Interferon-γ Producing CD8+ T Cells Increase During Immunosuppression Reduction to Treat Posttransplant Lymphoproliferative Disease. Transplantation. 84(11). 1534–1539. 20 indexed citations
7.
Guppy, Amy, Paul Nathan, & Gordon Rustin. (2005). Epithelial Ovarian Cancer: A Review of Current Management. Clinical Oncology. 17(6). 399–411. 86 indexed citations
8.
Guppy, Amy, Ann E. Nelstrop, Theresa Foster, et al.. (2004). A phase II study of sequential carboplatin, paclitaxel and topotecan in patients with previously untreated advanced ovarian cancer. British Journal of Cancer. 90(4). 810–814. 21 indexed citations
9.
Guppy, Amy, Niall C. Tebbutt, A. Norman, & David Cunningham. (2002). The Role of Surveillance CT Scans in Patients with Diffuse Large B-cell Non-Hodgkin's Lymphoma. Leukemia & lymphoma. 44(1). 123–125. 52 indexed citations
10.
Guppy, Amy & Gordon Rustin. (2002). CA125 Response: Can it Replace the Traditional Response Criteria in Ovarian Cancer?. The Oncologist. 7(5). 437–443. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026